Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...

Modest real-world weight loss may significantly reduce a person’s risk for cancer, according to results of a retrospective ...

Evidence suggests that sexual function may remain stable or improve after menopause, challenging assumptions of decline.

Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces that ...

Prestigious Publication Reinforces risto-cel’s Durable, Differentiated Clinical Data for the Treatment of SCD with Severe ...

Liver cancers are commonly thought to be driven by heavy alcohol use or chronic hepatitis B or C virus infection. But in this ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Phase II Study in Fragile X Syndrome -- IND clearance received from FDA; first patient enrollment targeted by year-end with ...

Background Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden cardiac death (SCD), and ...

Getting enough good-quality sleep is important for managing blood pressure. Taking measures to ensure you get a good night's ...

New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...

Objectives Fatigue is one of the most common and debilitating symptoms experienced by patients with systemic lupus erythematosus (SLE). Previous studies revealed the association of fatigue with ...